Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Healthcare
Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Ignore that clown randomtask
View:
Post by whisky11 on Aug 31, 2021 5:59pm

Ignore that clown randomtask

there is a couple of them attacking smaller companies I stood up to them. They working for someone with the money.
But that's not a problem, what I want to say is that in few months we will know how good R-107 is. 
If it meets expectation then... congratulation to all longs.
 
Comment by Chritters on Sep 01, 2021 11:01am
I ignore all you clowns, The only one with common sence on here is Raiders!!
Comment by randomtask on Sep 01, 2021 1:25pm
Don't be so sour about being out of your element;  investing, business, math and common sense simply aren't your strong suit :)
Comment by Raiders11 on Sep 01, 2021 3:24pm
This post has been removed in accordance with Community Policy
Comment by randomtask on Sep 01, 2021 4:01pm
This post has been removed in accordance with Community Policy
Comment by Raiders11 on Sep 01, 2021 4:06pm
This post has been removed in accordance with Community Policy
Comment by Raiders11 on Sep 01, 2021 4:09pm
This post has been removed in accordance with Community Policy
Comment by randomtask on Sep 01, 2021 4:09pm
This post has been removed in accordance with Community Policy
Claritas Pharmaceuticals Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities